Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer

Annals of Surgery

Volumn 253, Issue 3, 2011, Pages 539-545

  Lambregts, Doenja M J ^a,d   Beets, Geerard L ^d   Maas, Monique ^a,d   Kessels, Alfons G H ^a   Bakers, Frans C H ^a   Cappendijk, Vincent C ^a   Engelen, Sanne M E ^a   Lahaye, Max J ^a   De Bruïne, Adriaan P ^a   Lammering, Guido ^b,d   Leiner, Tim ^a   Verwoerd, Jan L ^c   Wildberger, Joachim E ^a   Beets Tan, Regina G H ^a,d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRO CLINIC   (Netherlands)

^c PHILIPS HEALTHCARE   (United States)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABLAVAR; CAPECITABINE; GADOFOSVESET; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; INTRAOPERATIVE RADIOTHERAPY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NODAL STAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOLOGIST; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; RECTUM RESECTION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TOTAL MESORECTAL EXCISION;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; ORGANOMETALLIC COMPOUNDS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; RECTUM; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 79951683610     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31820b01f1     Document Type: Article

References (31)

1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731-1740
2. Nagtegaal ID, Quirke P. What is the role of the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008;26:303-312
3. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646
4. Gosens MJ, van Krieken JH, Marijnen CA, et al. Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer. Clin Gastroenterol Hepatol. 2007;5:997-1003 (Pubitemid 47127021)
5. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779
6. Beets-Tan RG, Beets GL, Vliegen RF, et al. Accuracy of magnetic resonance imaging in prediction of tumor-free resection margin in rectal cancer surgery. Lancet. 2001;357:497-504 (Pubitemid 32173585)
7. Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors-the circumferential resection margin and nodal disease-of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MR. 2005;26:259-268 (Pubitemid 41111583)
8. Bipat S, Glas AS, Slors FJ, et al. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology. 2004;232:773-783 (Pubitemid 39100263)
9. Guillem JG, Diaz-Gonzalez JA, Minsky B, et al. cT3N0 rectal cancer: potential overtreatment with preoperative chemotherapy is warranted. J Clin Oncol. 2008;26:368-373 (Pubitemid 351171686)
10. Wang C, Zhou Z, Wang Z, et al. Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum. Langenbecks Arch Surg. 2005;390: 312-318 (Pubitemid 41110975)
11. Dworak O. Number and size of lymph nodes and node metastases in rectal carcinomas. Surg Endosc. 1989;3:96-99
12. Brown G, Richards CJ, Bourne MW, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227:371-377 (Pubitemid 36514749)
13. Lahaye MJ, Engelen SM, Kessels AG, et al. USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology. 2008;246:804-811
14. Koh D-M, Brown G, Temple L, et al. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings-initial observations. Radiology. 2004;231:91-99 (Pubitemid 38379645)
15. Will O, Purkayastha S, Chan C, et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. Lancet Oncol. 2006;7:52-60 (Pubitemid 43025393)
16. Gadofosveset: MS 325, MS 32520, Vasovist, ZK 236018. Drugs R D. 2004;5:339-342
17. Herborn CU, Lauenstein TC, Vogt FM, et al. Interstitial MR lymphography with MS-325: characterization of normal and tumor-invaded lymph nodes in a rabbit model. Am J Roentgenol. 2002;179:1567-1572 (Pubitemid 35386662)
18. Lahaye MJ, Beets GL, Engelen SME, et al. Gadovosfeset Trisodium (Vasovist®) enhanced MR lymph node detection: initial observations. Open MagneticReson J. 2009;2:1-5
19. Middleton PF, Sutherland LM, Maddern GJ. Transanal endoscopic microsurgery: a systematic review. Dis Colon Rectum. 2005;48:270-284 (Pubitemid 40576558)
20. Lezoche G, Baldarelli M, Guerrieri M, et al. A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. SurgEndosc. 2008;22:352-358
21. Borschitz T, Wachtlin D, Mohler M, et al. Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol. 2008;15:712-720
22. Habr-Gama A, Perez RO, Proscurshim I, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg. 2006;10:1319-1328
23. Shellock FG. The Reference Manual for Magnetic Resonance Safety, Implants and Devices (ed 2010). Los Angeles, CA, Biomedical Research Publishing Company
24. Marijnen CAM, Nagtegaal ID, Klein Kranenbarg E, et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol. 2001;7:1976-1984 (Pubitemid 32702542)
25. Kim JH, Beets GL, Kim MJ, et al. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol. 2004;52:78-83 (Pubitemid 39233657)
26. HealdRJ. Anew approach to rectal cancer. Br J Hosp Med. 1979;22:277-281
27. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845
28. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. 1st ed. New York, Chapman & Hall; 1993
29. Cohen J. Weighted Kappa: nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull. 1968;70:213-230
30. Lahaye MJ, Beets GL, Engelen SME, etal. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology. 2009;252:71-80
31. Koh DM, Chau I, Tait D, et al. Evaluating mesorectal lymph nodes in rectal cancer before and after chemoradiation using thin-section T2-weighted magnetic resonance imaging. Int JRadiat Oncol Biol Phys. 2008;71:456-461